The penetration rate for eye surgery in China is very low, according to Jørn Slot Jørgensen, chairman and CEO of EuroEyes. Photo: Shutterstock

German eye clinic group EuroEyes sets sights on US$90 million IPO in Hong Kong as investor sentiment starts to make a comeback

  • It is the latest in a series of initial public offerings (IPOs) returning to the city after confidence was damaged by the political crisis
Topic |   IPO

TOP PICKS

The penetration rate for eye surgery in China is very low, according to Jørn Slot Jørgensen, chairman and CEO of EuroEyes. Photo: Shutterstock
READ FULL ARTICLE